# INKT (MiNK Therapeutics, Inc.) - SEC EDGAR Financial Statements

> MiNK Therapeutics, Inc. reported $8.24M in total assets and a net loss of $11.02M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/INKT
- Markdown: https://convexityos.com/fundamentals/INKT.md
- SEC CIK: 0001840229
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840229&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$11.44M | Operating profit |
| Net Income | FY 2025 | -$11.02M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.16 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $7.47M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.76M | $6.34M | $15.49M | $23.12M | $13.97M | $9.51M |
| **Operating Income** | -$12.64M | -$11.29M | -$22.92M | -$30.95M | -$28.36M | -$14.64M |
| **EBITDA** | -$12.46M | -$11.07M | -$22.72M | -$30.83M | -$28.28M | -$14.58M |
| Interest Expense | -$110K | -$93K | -$28K | -- | $2.43M | $2.44M |
| **Net Income** | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M |
| Basic EPS | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | -$6.70 |
| **Diluted EPS** | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | -$6.70 |
| Basic Shares Outstanding | 4.3M | 3.8M | 3.4M | 3.4M | 2.6M | 2.4M |
| Diluted Shares Outstanding | 4.3M | 3.8M | 3.4M | 3.4M | 2.6M | 2.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $200K | -- | -- | -- | $0 | -- | -- | -- |
| Research & Development | $1.80M | $1.89M | $1.20M | $1.51M | $1.14M | $1.84M | $1.26M | $1.41M |
| **Operating Income** | -$2.64M | -$3.22M | -$2.88M | -$2.71M | -$3.18M | -$4.05M | -$2.70M | -$2.50M |
| **EBITDA** | -$2.60M | -$3.18M | -$2.85M | -$2.67M | -$3.14M | -$4.00M | -$2.65M | -$2.45M |
| Interest Expense | -$1.0K | -$2.0K | -$4.0K | -$29K | -$25K | -$27K | -$29K | -$30K |
| **Net Income** | -$2.55M | -$3.13M | -$2.74M | -$2.60M | -$2.89M | -$4.24M | -$2.77M | -$2.46M |
| Basic EPS | -$0.50 | -$0.62 | -$0.57 | -- | -$0.65 | -$1.06 | -$0.70 | -- |
| **Diluted EPS** | -$0.50 | -$0.62 | -$0.57 | -- | -$0.65 | -$1.06 | -$0.70 | -- |
| Basic Shares Outstanding | 5.1M | 5.0M | 4.8M | -- | 4.4M | 4.0M | 4.0M | -- |
| Diluted Shares Outstanding | 5.1M | 5.0M | 4.8M | -- | 4.4M | 4.0M | 4.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $13.36M | $4.58M | $3.37M | $19.64M | $38.89M | $2.69M |
| **Cash & Short-Term Investments** | $13.36M | $4.58M | $3.37M | $19.64M | $38.89M | $2.69M |
| Other Current Assets | $211K | $164K | $178K | $470K | $744K | $914K |
| **Total Current Assets** | $13.85M | $4.99M | $3.60M | $20.40M | $39.63M | $4.10M |
| Property, Plant & Equipment, Net | $391K | $733K | $954K | $1.07M | $607K | $458K |
| **Total Non-Current Assets** | $391K | $733K | $954K | $1.07M | $607K | $458K |
| **Total Assets** | $14.24M | $5.72M | $4.55M | $21.47M | $40.24M | $4.56M |
| Accounts Payable | $3.43M | $2.73M | $3.91M | $5.82M | $3.00M | $3.14M |
| Other Current Liabilities | $2.85M | $2.36M | $2.45M | $2.62M | $5.76M | $5.69M |
| **Total Current Liabilities** | $13.03M | $6.96M | $11.40M | $12.68M | $16.47M | $14.22M |
| Other Non-Current Liabilities | -- | $0 | $48K | $108K | -- | $383K |
| **Total Non-Current Liabilities** | $15.44M | $18.35M | $11.21M | $9.19M | $0 | $44.21M |
| **Total Liabilities** | $28.47M | $25.31M | $22.61M | $21.87M | $16.47M | $58.43M |
| Common Stock | $48 | $40 | $35 | $339 | $335 | $242 |
| Retained Earnings | -$156.7M | -$144.2M | -$133.4M | -$110.9M | -$82.95M | -$52.74M |
| Accumulated Other Comp. Income | -$719K | -$632K | -$431K | -$292K | -$625K | -$1.52M |
| **Total Stockholders' Equity** | -$14.23M | -$19.59M | -$18.06M | -$401K | $23.78M | -$53.87M |
| Total Equity | -$14.23M | -$19.59M | -$18.06M | -$401K | $23.78M | -$53.87M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.47M | $8.81M | $9.53M | $13.36M | $9.50M | $1.68M | $3.23M | $4.58M |
| **Cash & Short-Term Investments** | $7.47M | $8.81M | $9.53M | $13.36M | $9.50M | $1.68M | $3.23M | $4.58M |
| Other Current Assets | $85K | $212K | $232K | $211K | $32 | $55K | $109K | $164K |
| **Total Current Assets** | $7.90M | $9.30M | $10.02M | $13.85M | $14.53M | $2.01M | $3.58M | $4.99M |
| Property, Plant & Equipment, Net | $339K | $318K | $355K | $391K | $429K | $473K | $688K | $733K |
| **Total Non-Current Assets** | $339K | $318K | $355K | $391K | $429K | $473K | $688K | $733K |
| **Total Assets** | $8.24M | $9.62M | $10.38M | $14.24M | $14.96M | $2.48M | $4.27M | $5.72M |
| Accounts Payable | $4.49M | $3.92M | $3.39M | $3.43M | $3.69M | $3.31M | $2.66M | $2.73M |
| Other Current Liabilities | $2.37M | $2.45M | $2.57M | $2.85M | $2.76M | $2.48M | $2.37M | $2.36M |
| **Total Current Liabilities** | $8.18M | $7.57M | $7.29M | $13.03M | $13.43M | $13.16M | $12.12M | $6.96M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $16.32M | $16.07M | $15.78M | $15.44M | $15.04M | $14.51M | $13.94M | $18.35M |
| **Total Liabilities** | $24.49M | $23.64M | $23.06M | $28.47M | $28.48M | $27.67M | $26.06M | $25.31M |
| Common Stock | $52 | $52 | $51 | $48 | $46 | $40 | $40 | $40 |
| Retained Earnings | -$165.1M | -$162.5M | -$159.4M | -$156.7M | -$154.1M | -$151.2M | -$146.9M | -$144.2M |
| Accumulated Other Comp. Income | -$704K | -$700K | -$697K | -$719K | -$692K | -$719K | -$662K | -$632K |
| **Total Stockholders' Equity** | -$16.25M | -$14.03M | -$12.69M | -$14.23M | -$13.51M | -$25.19M | -$21.79M | -$19.59M |
| Total Equity | -$16.25M | -$14.03M | -$12.69M | -$14.23M | -$13.51M | -$25.19M | -$21.79M | -$19.59M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M |
| Depreciation & Amortization | $182K | $215K | $205K | $122K | $78K | $55K |
| Stock-Based Compensation | $2.67M | $1.81M | $3.86M | $3.03M | $1.74M | $88K |
| Change in Payables | $690K | -$1.18M | -$1.92M | $2.66M | -$152K | $608K |
| **Operating Cash Flow** | -$5.93M | -$9.56M | -$15.76M | -$18.87M | -$12.83M | -$8.34M |
| Capital Expenditure | -- | -- | -$74K | -$250K | -$249K | -$95K |
| **Free Cash Flow** | -- | -- | -$15.84M | -$19.12M | -$13.08M | -$8.43M |
| **Investing Cash Flow** | -- | -- | -$74K | -$250K | -$249K | -$95K |
| Common Stock Issued | $14.45M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $14.72M | $10.82M | -$407K | -$156K | $49.26M | $11.11M |
| **Net Change in Cash** | $8.78M | $1.21M | -$16.27M | -$19.25M | $36.20M | $2.39M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.55M | -$3.13M | -$2.74M | -$2.60M | -$2.89M | -$4.24M | -$2.77M | -$2.46M |
| Depreciation & Amortization | $36K | $36K | $36K | $39K | $44K | $49K | $51K | $54K |
| Stock-Based Compensation | $333K | $422K | $630K | $566K | $621K | $897K | $591K | $390K |
| Change in Payables | $570K | $527K | -$32K | -$270K | $382K | $646K | -$69K | $374K |
| **Operating Cash Flow** | -$1.28M | -$2.08M | -$1.73M | -$2.07M | -$941K | -$1.57M | -$1.34M | -$1.73M |
| Common Stock Issued | $0 | $1.37M | $3.02M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $0 | $1.37M | -$2.10M | $1.18M | $13.55M | $540 | $576 | -$3 |
| **Net Change in Cash** | -$1.34M | -$719K | -$3.83M | -$921K | $12.60M | -$1.55M | -$1.34M | -$1.75M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -127.1% | -- |
| Return on Assets (ROA) | -87.7% | -188.5% | -493.3% | -130.4% | -75.1% | -356.5% |
| Current Ratio | 1.06x | 0.72x | 0.32x | 1.61x | 2.41x | 0.29x |
| Quick Ratio | 1.03x | 0.66x | 0.30x | 1.55x | 2.36x | 0.19x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -133.7% | -118.1% | -120.2% | -87.7% | -82.6% | -453.8% | -228.2% | -188.5% |
| Current Ratio | 0.97x | 1.23x | 1.38x | 1.06x | 1.08x | 0.15x | 0.30x | 0.72x |
| Quick Ratio | 0.91x | 1.16x | 1.31x | 1.03x | 0.71x | 0.13x | 0.27x | 0.66x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
